New Canine (dog) Sertoli cells for sale, 1 mL stock vials New Approach Methodologies · Animal-free

In vitro reproductive toxicity testing with 3D mini-testis models

Reprotox Biotech helps drug-development and chemical-safety teams predict male reproductive toxicity using multi-species 3D mini-testis models and testicular organoids (rodent, canine and human), high-content imaging and machine-learning analysis.

NIH SBIR Phase I & II NIH Complement-ARIE Prize 2025 20+ peer-reviewed papers
Reprotox scientist preparing a 96-well plate in a biosafety cabinet
91.5%sensitivity vs. in vivo data
93.8%specificity vs. in vivo data
Funded & recognized by
NIH SBIR Phase INIEHS R43ES031890
NIH SBIR Phase IINIEHS R44ES027374
NIH Complement-ARIEChallenge Prize, 2025
RDTSS Best PaperToxicological Sciences, 2025
Validated performance

Data you can bring to a safety decision

Our 3D mini-testis model was profiled against 87 reference compounds and benchmarked against traditional in vivo reproductive toxicity data.

91.5%Sensitivity compared with in vivo outcomes
93.8%Specificity compared with in vivo outcomes
150Compounds in our reproductive toxicity database
10+High-content endpoints per compound, incl. F-actin & γH2AX
Services

From screening to mechanism

Standard assays or a study designed around your compounds, timelines and regulatory questions.

Fluorescence image of 3D testicular cell culture

3D In Vitro Reproductive Models

Mini-testis co-cultures of spermatogonia, Sertoli and Leydig cells in an ECM scaffold. Available for mouse, rat, canine and human.

Explore models
High-content image of stained testicular cells

High-Content Image Analysis

Automated high-throughput imaging with multi-parametric, AOP-aligned phenotypic profiling and machine-learning analysis.

See assays
Customized in vitro toxicity testing

Customized Toxicity Testing

Affordable, scalable study designs for drugs and environmental chemicals, with clear reporting.

Design a study

Canine Sertoli Cells for Sale

Primary canine (dog) Sertoli cells in 1 mL stock vials. Rat Sertoli cells on request. Order →

Mechanism Studies

Cell-specific pathways, DNA damage and cytoskeletal disruption.

Consultation

Reproductive toxicology assessment and NAM strategy support.

How it works

A clear path from question to answer

Consult

Tell us about your compounds, species of interest and the decision you need to make.

Design

We propose models, endpoints, concentrations and timelines, plus a quote.

Test

Compounds run in 3D mini-testis models with automated high-content imaging.

Report

Quantitative, mechanism-informed results with ML-based hazard prioritization.

Figure from Toxicological Sciences 2025 publication
Featured research · Best Paper 2025

High-content profiling of 87 compounds in a 3D mini-testis model

Yin L, Hu JC, Xia M, Yu X. Toxicological Sciences. 2025;208(2):279–300.

  • A New Approach Methodology for prioritizing male reproductive toxicants
  • Recognized with the RDTSS Best Paper in Toxicological Sciences award
  • Basis for a filed US non-provisional patent application
Latest news

What we've been up to

All news
Award · 2026

RDTSS Best Paper in Toxicological Sciences

Recognized for our high-content toxicological profiling of 87 compounds using a 3D mouse mini-testis model.

Read more
Conference · 2026

Presenting at SOT 2026, San Diego

New work on microplastic accumulation in mammalian reproductive tissues, comparing domestic dogs and human samples.

Read more
Funding · Oct 2025

FY26 New Mexico Science & Technology Startup Grant

Awarded by the Technology Research Collaborative Board and the New Mexico Economic Development Department.

Read more
About Reprotox Biotech

Specialists in in vitro male reproductive toxicology

Reprotox Biotech LLC is a biotechnology company in the UNM Science & Technology Park in Albuquerque, New Mexico. We develop and validate animal-free New Approach Methodologies (NAMs) for reproductive toxicology: 3D mini-testis models and testicular organoids, high-content imaging assays, machine-learning analysis and primary testicular cells such as canine Sertoli cells.

Our work is supported by NIH SBIR Phase I and Phase II funding from NIEHS and recognized with the NIH Complement-ARIE Challenge Prize and the RDTSS Best Paper in Toxicological Sciences.

Reprotox Biotech (rptox.com) is an independent company and is not affiliated with the REPROTOX® reproductive toxicology database (reprotox.org).

FAQ

Common questions

What is in vitro reproductive toxicology testing?

It evaluates whether drugs or chemicals harm reproductive cells and tissues using cell-based models instead of live animals. We focus on male reproductive toxicity, testing compounds on 3D mini-testis models and testicular cells to identify hazards early in drug discovery and chemical safety assessment.

What is a 3D mini-testis model?

A three-dimensional co-culture of spermatogonia, Sertoli and Leydig cells in an extracellular matrix that mimics the structure and signaling of the testis. Our models are available from mouse, rat and canine sources, including stage-specific testicular organoids.

How predictive are your models?

In a peer-reviewed study of 87 reference compounds, our 3D mini-testis model showed 91.5% sensitivity and 93.8% specificity compared with traditional in vivo reproductive toxicity data (Yin et al., Toxicological Sciences 2025).

How is this different from a standard cytotoxicity assay?

Standard assays only measure whether cells die. Our high-content analysis measures 10+ endpoints and 200+ features per cell, detecting DNA damage, cell-cycle and cytoskeletal effects below lethal doses. See the comparison.

Can I buy canine Sertoli cells?

Yes. Primary canine (dog) Sertoli cells (catalog CS-SCs) are available in 1 mL stock vials, with over 95% purity by SOX9 and GATA4. View the product or request a quote.

Planning a reproductive safety study?

Talk to our toxicologists about models, endpoints and timelines for your compounds.